KANTAR HEALTH ONCOLOGY SOLUTIONS:FOCUSED I DEDICATED I HERITAGE

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER.

CATALYSTS DRIVING SUCCESSFUL DECISIONS IN

LIFE SCIENCES

2 | | 3

AT KANTAR HEALTH, ONCOLOGY IS WHAT WE DO! WE ARE GLOBAL EXPERTS IN BRINGING TOGETHER SCIENTIFIC AND COMMERCIAL RESEARCH TO DELIVER THE UNIQUE ONCOLOGY INSIGHTS AND COMMERCIAL STRATEGIES YOU NEED TO ACHIEVE BRAND SUCCESS.

Kantar Health oncology solutions offers:

+ 25+ years of deep oncology expertise and thought leadership.

+ More than 100 dedicated oncology experts.

+ 65+ PhDs, Pharm D, and MDs.

+ 30 ex-pharma market access and commercial brand experts.

+ 400+ market researchers, consultants, data scientists and creatives.

+ Offices across the globe, on 5 continents and in 40 countries.

+ 500+ custom oncology engagements in the last year alone covering more than 50 solid tumors and hematologic malignancies.

+ A wide breadth of work with more than 150 oncology clients, including Big Pharma, BioTech, research and non-profit companies.

+ An extensive published research record, with more than 120 oncology-related publications in conferences and medical journals.

+ Impactful global qualitative and quantitative research, with experts who have native language skills.

+ Proprietary data resources not found anywhere else in the industry.

Our engagements span the product lifecycle from early-stage/discovery to post-marketing/surveillance. Only Kantar Health oncology solutions combines experts, data and insights with the analytics and tools necessary for product growth.

WORLD CLASS EXPERTISE, EXPERIENCE AND DATA ASSETS Kantar Health oncology solutions is the one place where Expertise, Experience and proprietary data resources intersect to deliver valuable insights to help you navigate the complex and ever-evolving oncology landscape. Simply, our experts convert complex nuances within the oncology landscape into simple, actionable business solutions.

We’re recognized globally as leaders in oncology consulting and market research by the world’s most trusted oncology companies. We’ll provide you with the insights, resources, and data needed to determine commercial potential and optimal market strategy, ultimately increasing the probability of commercial success.

Kantar Health has the unique ability to collect, analyze, and interpret customized datasets, including linked data sources, enabling us to make strategic recommendations for winning commercial decisions.

4 | | 5

FOCUSED: THREE AREAS OF DISCIPLINEOur oncology experts focus on three areas that address key elements across the product lifecycle: Portfolio Planning, Clinical Development Strategy and Commercial Planning and Insights are the disciplines that form the structural foundation of Kantar Health Oncology.

+ Portfolio Prioritization

+ Competitive Intelligence

+ Clinical Evaluations

+ Competitive Event Assessment

+ Epidemiology/Patient Targeting

+ Market Access & Pricing

+ Market Landscape Assessment

+ Patient Journey/Buying Process

+ Segmentation

+ Brand Positioning

+ Key Influencer/Stakeholder Mapping

+ Brand Equity Evaluation: PINNAKLE™

+ Qualitative & Quantitative Market Research

+ Clinical Trial Optimization

+ Market Sizing & Epidemiology

+ Tumor Landscape Assessments

+ Competitive Positioning Analysis

+ Target Product Profile Assessment

+ KOL Assessment

+ Brand & Franchise Commercial Strategy

PORTFOLIO PLANNING

CLINICAL DEVELOPMENT STRATEGY

COMMERCIAL PLANNING & INSIGHTS

Pre-clinical Pre-launch Launch Post Launch

Brand Optimization

6 | | 7

DEDICATED: SIX EXPERT ONCOLOGY TEAMSOncology is what we do, and Kantar Health’s oncology solutions are supported by six expert oncology teams that provide specialized knowledge and proficiency related to specific areas of the oncology market.

While each team has their own expertise, Kantar Health brings together multiple teams to provide creative, innovative solutions to your specific business needs – no request is too big or small.

We leverage the knowledge of oncology consulting, health outcomes, market access, and marketing insights to build patient, physician, payer, and / or caregiver preference studies to better understand the picture of what patients and providers hope to achieve with new drug regimens.

CLINICAL AND SCIENTIFIC CONSULTING

EPIDEMIOLOGY

MARKET ACCESS & COMMERCIAL STRATEGY

FORECASTING AND ANALYTICS

QUALITATIVE AND QUANTITATIVE RESEARCH & INSIGHTS ANALYTICS

REAL WORLD EVIDENCE

Our clients receive exclusive access to oncology stakeholders through Kantar’s Lightspeed panel of payors and providers

We work with a blended team of epidemiology, oncology consulting, and forecasting experts to determine how new data and current agents will shape your agent’s entry into the market.

8 | | 9

HERITAGE: PROPRIETARY ONCOLOGY RESOURCESKantar Health oncology solutions provides clients with a heritage of proprietary data resources not found anywhere else in the industry! For more than 20 years we have supplied the industry with a wide variety of oncology resources that the world’s top oncology companies depend on.

10 | | 11

CANCERMPACT®

Getting from A to Z begins with CancerMPact® – the premier global oncology intelligence resource.

CancerMPact features four integrated modules designed to provide clients with comprehensive business insights for the dynamic oncology landscape. CancerMPact covers more than 37 different tumor types across the US, EU-5, Japan, China and 9 additional countries.

4 MODULES

Patient Metrics – this cancer epidemiology module leverages data from cancer registries and combine it with expert analysis to act as the starting point for understanding your target population together with detailed treatment data to size any given tumor type.

Treatment Architecture – this module leverages robust primary market research surveys of physicians to gain a detailed understanding the current clinical management of cancer patients by tumor type, site, disease stage, treatment modalities, and drug therapy use.

Future Trends and Insights – this module delivers expert insights on impending changes in the competitive landscape in each tumor market, including new product introductions and label expansions of market products.

CancerNFluence®: Oncology KOL Mapping – this key opinion leader (KOL) mapping module, driven by our proprietary CancerNFluence offering, delivers profiles of leading physicians in the United States and Europe who influence treatment decisions across multiple cancer types.

CANCERLANDSCAPETM

The CancerLandscape platform is an innovative, dynamic, web-based solution with an easy to navigate, visually impactful and highly interactive dashboard that makes data easy to interpret.

Offering fast navigation of large datasets to better understand oncology medicine opportunities and the competitive landscape, CancerLandscape assists users in evaluating business development and licensing opportunities, identifying novel targets for drug development, comparing company pipelines, and understanding the competitive landscapes in multiple tumor types.

ONCOLOGY FORECAST ARCHITECT®

Oncology Forecast Architect offers the flexibility to meet the unique requirements of oncology product forecasting and the functionality to simplify the modeling process so that users may focus on assumptions.

Our cancer patient flow forecast approach takes into account: the partitioning of patients into commercially relevant segments, including lines of therapy, exposure of prior therapies, biomarkers, and varying competitive sets; and underlying assumptions for treatment allocation and rates of progression through various therapies.

Key challenges addressed include:

+ Precise calculations of “Patients on Therapy”

+ Irregular dosing patterns

+ Treatment discontinuations

+ Linking lines of therapy

+ “Re-Treatment”

+ Spanning treatment durations longer than one year

ONCOLOGY MARKET ACCESS

Kantar Health’s U.S. OMA deeply examines complex treatment and care dynamics through a multi-stakeholder lens delivering key insights that inform your commercial and market access strategies.

Our OMA team routinely evaluates stakeholder dynamics in the cancer market, including exploring the impact of healthcare reform on oncology care. Additionally, we assess the changing structure of the cancer care delivery system, focusing on the treatment and business challenges and opportunities faced by oncologists, patients and payers as a result of the coverage policy and reimbursement trends that influence prescribing and impact affordability.

Our OMA report features 10 modules, including:

+ Cancer Care Dynamics

+ Treatment Dynamics Trends

+ Tumor-Specific Cancer Treatment Dynamics

+ Government Health Policy Trends

+ Patient Influence and Affordability

+ Payer Mix Simulations

+ Immunotherapy in Oncology

+ Distribution Channel Dynamics

FOR MORE INFORMATION

Please contact us at info@kantarhealth.com, or visit www.kantarhealth.com.

ABOUT KANTAR HEALTH

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 600+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit www.kantarhealth.com.